Exelixis, Inc. (LON:0IJO)
London · Delayed Price · Currency is GBP · Price in USD 37.77
+1.09 (2.98%)
At close: Aug 1, 2025
Kronos Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 602.3 | 521.27 | 207.77 | 182.28 | 231.06 | 111.78 | Upgrade |
Depreciation & Amortization | 29.78 | 28.8 | 25.72 | 20.88 | 13.63 | 9.14 | Upgrade |
Asset Writedown & Restructuring Costs | 95.64 | 115.14 | 128.5 | 107.25 | 14 | - | Upgrade |
Stock-Based Compensation | 111.37 | 93.84 | 106.35 | 107.57 | 119.82 | 105.07 | Upgrade |
Other Operating Activities | -65.94 | -45.62 | -121.03 | -42.57 | 61.3 | 23.13 | Upgrade |
Change in Accounts Receivable | 104.43 | -27.95 | -22.62 | 66.85 | -122.32 | -42.47 | Upgrade |
Change in Inventory | 4.95 | 5.45 | -12.98 | -11.68 | -13.21 | -21.9 | Upgrade |
Change in Accounts Payable | -26.37 | -21.89 | 50.11 | 23.36 | 55.09 | 50.51 | Upgrade |
Change in Unearned Revenue | - | - | - | - | 11.01 | -1.05 | Upgrade |
Change in Other Net Operating Assets | -84.13 | 30.93 | -28.48 | -91.32 | 30.42 | -25.23 | Upgrade |
Operating Cash Flow | 772.03 | 699.97 | 333.32 | 362.61 | 400.8 | 208.98 | Upgrade |
Operating Cash Flow Growth | 144.08% | 110.00% | -8.08% | -9.53% | 91.79% | -60.34% | Upgrade |
Capital Expenditures | -17.96 | -28.44 | -40.47 | -27.71 | -54.23 | -30.35 | Upgrade |
Sale (Purchase) of Intangibles | -31.25 | -37.75 | -122.5 | -110.75 | -10 | - | Upgrade |
Investment in Securities | 36.66 | -50.6 | 136.01 | -385.96 | 21.34 | -100.87 | Upgrade |
Investing Cash Flow | -12.55 | -116.78 | -26.96 | -524.41 | -42.88 | -131.22 | Upgrade |
Issuance of Common Stock | 76.32 | 61.85 | 33.45 | 23.89 | 24.31 | 24.89 | Upgrade |
Repurchase of Common Stock | -869.83 | -690.66 | -579.5 | -23.3 | -39.11 | -50.02 | Upgrade |
Financing Cash Flow | -793.5 | -628.81 | -546.05 | 0.59 | -14.8 | -25.13 | Upgrade |
Net Cash Flow | -34.03 | -45.62 | -239.68 | -161.21 | 343.12 | 52.64 | Upgrade |
Free Cash Flow | 754.07 | 671.54 | 292.86 | 334.91 | 346.58 | 178.64 | Upgrade |
Free Cash Flow Growth | 171.70% | 129.31% | -12.56% | -3.37% | 94.01% | -65.25% | Upgrade |
Free Cash Flow Margin | 33.81% | 30.96% | 16.00% | 20.79% | 24.15% | 18.09% | Upgrade |
Free Cash Flow Per Share | 2.61 | 2.27 | 0.91 | 1.03 | 1.07 | 0.56 | Upgrade |
Cash Income Tax Paid | 170.48 | 170.48 | 185.66 | 127.87 | 12.96 | 4.12 | Upgrade |
Levered Free Cash Flow | 637.96 | 464.22 | 125.4 | 147.55 | 250.4 | 134.36 | Upgrade |
Unlevered Free Cash Flow | 637.96 | 464.22 | 125.4 | 147.55 | 250.4 | 134.36 | Upgrade |
Change in Net Working Capital | -76.19 | 23.45 | -49.5 | -31.63 | -2.01 | 18.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.